Dogwood Therapeutics, Inc.

US$1.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DWTXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (57.35%)
Div yield —
ROE (47.77%)
Biotechnology
Beta (5Y) 2.11
PE TTM —
TSR TTM (79.39%)
Mkt cap US$48.93M
ROIC (15.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.59
23.86%
(88.14%)
Hold 4|1|7|3|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
18.99%
19.82%
31.79%
32.60%
Revenue$M
2.190
2.294
2.373
2.447
0.82%
2.32%
8.74%
15.39%
Peers (US$48.93M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.210
—
—
EBIT/Intx
9.801
0.729
0.660
Own earn%
(75.26)
(90.35)
(91.11)
Sh yield%
20.01
44.57
48.42
Owners
Insiders/Inst%
10.90
57.92
Short interest%
4.48
SBC / revenue%
5.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
16